On September 21, the Jingdong Group released an announcement confirming that, with JD Health as a subsidiary of the Jingdong collective, Jingdong Group plans to separately list JD Health on the main board of the Stock Exchange of Hong Kong.

JD Health’s main businesses include pharmaceutical retailing and Internet medical services. The former one includes self-managed retailers and platform models; the latter one mainly focuses on patients’ needs, such as online appointment, online consultation and other online medical services, along with Jingdong’s unique pharmaceutical supply chain advantages. (Source: xinhuanet)

Comments are closed.